Literature DB >> 12187003

The effect of combined therapy with immunoadsorption and high-dose intravenous methylprednisolone on myasthenia gravis.

Reiko Munakata1, Kimiaki Utsugisawa, Yuriko Nagane, Munehisa Yamagata, Miyuki Oikawa, Daiji Obara, Hideo Tohgi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12187003     DOI： 10.1159/000062987

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  5 in total

Review 1.  Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.

Authors:  Yoshihisa Kadota; Hirotoshi Horio; Takeshi Mori; Noriyoshi Sawabata; Taichiro Goto; Shin-ichi Yamashita; Takeshi Nagayasu; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-01-22

Review 2.  Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis.

Authors:  Liang Wang; Suxian Zhang; Jianying Xi; Wenhui Li; Lei Zhou; Jun Lu; Jiahong Lu; Tiansong Zhang; Chongbo Zhao
Journal:  J Neurol       Date:  2017-09-18       Impact factor: 4.849

Review 3.  Therapeutic Plasma Exchange: For Cancer Patients.

Authors:  Yuru Hu; Hanshan Yang; Shaozhi Fu; Jingbo Wu
Journal:  Cancer Manag Res       Date:  2022-02-02       Impact factor: 3.989

4.  Myasthenia Gravis Complicated by Eosinophilic Granulomatosis with Polyangiitis: A Case Report.

Authors:  Takahumi Uchi; Shingo Konno; Hideo Kihara; Mari Matsushima; Hideki Sugimoto; Toshiaki Oharaseki; Kei Takahashi; Toshiki Fujioka
Journal:  Case Rep Neurol       Date:  2022-07-11

Review 5.  Current Treatment of Myasthenia Gravis.

Authors:  Mohammed K Alhaidar; Sumayyah Abumurad; Betty Soliven; Kourosh Rezania
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.